{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:34:45Z","timestamp":1761921285445,"version":"3.37.3"},"reference-count":41,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Addict"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and Objectives<\/jats:title><jats:p>As overdose rates rise among non\u2010White Americans, understanding barriers to substance use disorder (SUD) treatment access by race and ethnicity is important. This study explores self\u2010reported barriers to SUD treatment by race and ethnicity in emergency department (ED) populations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a secondary, exploratory analysis of a randomized trial of patients not seeking SUD treatment who endorsed active drug use at six academic EDs. Responses to the Barriers to Treatment Inventory were compared by race, ethnicity, and drug severity, using \u03c7<jats:sup>2<\/jats:sup> tests (<jats:italic>N<\/jats:italic>\u2009=\u2009858), followed by adjusted logistic regression models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Absence of a perceived drug problem (39% non\u2010Hispanic Black, 38% Hispanic, 50% non\u2010Hispanic White; <jats:italic>p<\/jats:italic>\u2009\u2264\u2009.001) was the most prevalent barrier to SUD treatment. Non\u2010Hispanic Black participants were less likely to state that they could handle their drug use on their own (OR\u2009=\u20090.69, CI\u2009=\u20090.50\u20130.95), and were more likely to report disliking personal questions than non\u2010Hispanic White participants (OR\u2009=\u20091.49, CI\u2009=\u20091.07\u20132.09). Non\u2010Hispanic Black participants were less likely than Hispanic participants to agree that treatment availability (OR\u2009=\u20090.46, CI\u2009=\u20090.28\u20130.76) and family disapproval (OR\u2009=\u20090.38, CI\u2009=\u20090.16\u20130.91) were treatment barriers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion and Conclusions<\/jats:title><jats:p>Screening and counseling may help address the barrier, common to all groups, that drug use was not seen as problematic. Expanding access to diverse treatment options may also address the range of barriers reported by our study population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Scientific Significance<\/jats:title><jats:p>Our study is one of the first in the U.S. to examine both individual and structural barriers to accessing treatment and to examine the association with drug use severity by race\/ethnicity.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ajad.13631","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T05:55:01Z","timestamp":1722923701000},"page":"631-640","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Racial and ethnic differences in self\u2010reported barriers to substance use treatment among emergency department patients"],"prefix":"10.1111","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0658-5340","authenticated-orcid":false,"given":"Neha Jia","family":"Ahmad","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Harvard Affiliated Emergency Medicine Residency Massachusetts General Hospital and Brigham and Women's Hospital Boston Massachusetts USA"},{"name":"Department of Emergency Medicine Massachusetts General Hospital Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Division of Alcohol, Drugs, and Addiction McLean Hospital Belmont Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8971-846X","authenticated-orcid":false,"given":"Margaret L.","family":"Griffin","sequence":"additional","affiliation":[{"name":"Division of Alcohol, Drugs, and Addiction McLean Hospital Belmont Massachusetts USA"},{"name":"Department of Psychiatry Harvard Medical School Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7503-828X","authenticated-orcid":false,"given":"Roger D.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Division of Alcohol, Drugs, and Addiction McLean Hospital Belmont Massachusetts USA"},{"name":"Department of Psychiatry Harvard Medical School Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy L.","family":"Macias\u2010Konstantopoulos","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Harvard Affiliated Emergency Medicine Residency Massachusetts General Hospital and Brigham and Women's Hospital Boston Massachusetts USA"},{"name":"Department of Emergency Medicine Massachusetts General Hospital Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,8,5]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.0004"},{"key":"e_1_2_8_3_1","doi-asserted-by":"crossref","unstructured":"MadrasBK AhmadNJ WenJ SharfsteinJ.Improving access to evidence\u2010based medical treatment for opioid use disorder: strategies to address key barriers within the treatment system.NAM Perspect.2020:1\u201037.https:\/\/nam.edu\/wp-content\/uploads\/2020\/04\/Improving-Access-to-Evidence-Based-Medical-Treatment-for-OUD_FINAL.pdf","DOI":"10.31478\/202004b"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15384"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"volume-title":"Key substance use and mental health indicators in the United States: results from the 2021 National Survey on Drug Use and Health (HHS Publication No. PEP22\u201007\u201001\u2010005, NSDUH Series H\u201057)","year":"2022","author":"Substance Abuse and Mental Health Services Administration","key":"e_1_2_8_6_1"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.06.011"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.0876"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.03.028"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.06.009"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2018.08.004"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2015.09.006"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2011.0983"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.12.2027"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000001294"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.05.017"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2006.08.032"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2016.12.013"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.11.006"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2011.596971"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4603(82)90005-3"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.08.002"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.01.002"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.4052"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-018-0120-6"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S183252"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/10673220490905723"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.17206"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2012.07.005"},{"key":"e_1_2_8_30_1","unstructured":"U.S. Census Bureau. QuickFacts. West Virginia.2021."},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/1077558700057001S09"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2010.06.090264"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.07.027"},{"key":"e_1_2_8_34_1","unstructured":"The Lewin Group Inc.Indicators of cultural competence in health care delivery organizations: an organizational cultural competence assessment profile.Prepared for the Health Resources and Services Administration U.S. Department of Health and Human Services;2002."},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.04.005"},{"volume-title":"Key substance use and mental health indicators in the United States: results from the 2022 National Survey on Drug Use and Health (HHS Publication No. PEP23\u201007\u201001\u2010006, NSDUH Series H\u201058)","year":"2023","author":"Substance Abuse and Mental Health Services Administration","key":"e_1_2_8_36_1"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107616"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2018.05162"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001287"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2023.03.025"},{"key":"e_1_2_8_41_1","unstructured":"Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H\u201046 HHS Publication No. (SMA) 13\u20104795.2013.https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUHnationalfindingresults2012\/NSDUHnationalfindingresults2012\/NSDUHresults2012.htm#ch7.2"},{"key":"e_1_2_8_42_1","unstructured":"Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: results from the 2020 National Survey on Drug Use and Health. HHS Publication No PEP19\u20105068 NSDUH Series H\u201054.2021;170:1\u201062."}],"container-title":["The American Journal on Addictions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajad.13631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T01:14:39Z","timestamp":1729818879000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajad.13631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,5]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1111\/ajad.13631"],"URL":"https:\/\/doi.org\/10.1111\/ajad.13631","archive":["Portico"],"relation":{},"ISSN":["1055-0496","1521-0391"],"issn-type":[{"type":"print","value":"1055-0496"},{"type":"electronic","value":"1521-0391"}],"subject":[],"published":{"date-parts":[[2024,8,5]]},"assertion":[{"value":"2023-12-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}